{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-001972","form_type":"8-K","ticker":"UG","cik":"0000101295","company_name":"UNITED GUARDIAN INC","filed_at":"2026-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.396825+00:00","generated_at":"2026-05-15T08:30:36.221745+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"United-Guardian FY2025 net sales down 13% to $10.5M; net income falls to $2.1M ($0.46/share)","bullets":["Net sales $10.5M, down 13% from $12.2M in FY2024; net income $2.1M ($0.46/share) vs $3.3M ($0.71/share) prior year.","Cosmetic ingredient sales declined due to excess inventory at distributor Ashland Specialty Ingredients and weaker China demand.","Pharmaceuticals up 15%, medical lubricants up 4% YoY; Renacidin added to two major pharmacy benefit manager formularies.","Management optimistic about new marketing agreements and distributor efforts to regain market share in coming years."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-001972","json":"https://secwatch.observer/filing/0001171843-26-001972.json","markdown":"https://secwatch.observer/filing/0001171843-26-001972.md","text":"https://secwatch.observer/filing/0001171843-26-001972.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/101295/000117184326001972/0001171843-26-001972-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/101295/000117184326001972/f8k_032626.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:30:36.221745+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0c23ac9f527b05432c34abd183a67b81e7a8fba2","claim":"UNITED GUARDIAN INC reported FY 2025 results: revenue $10,545,468, net income $2,105,738, EPS $0.46 per share.","evidence_excerpt":"United-Guardian Reports 2025 Financial Results HAUPPAUGE, N.Y., March 27, 2026 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) reported that net sales and net income for FY 2025 decreased compared to FY 2024. Net sales for the year decreased by 13% from $12,181,971 in 2024 to $10,545,468 in 2025, generating net income of $3,250,875 ($0.71 per share) in 2024 compared to $2,105,738 ($0.46 per share) in 2025.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/101295/000117184326001972/0001171843-26-001972-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"FY 2025"},{"label":"Revenue","value":"$10,545,468"},{"label":"Net income","value":"$2,105,738"},{"label":"EPS","value":"$0.46 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}